B. Metzler seel. Sohn & Co’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-34,418
| Closed | -$636K | – | 777 |
|
|
2024
Q3 | $636K | Hold |
34,418
| – | – | 0.01% | 615 |
|
|
2024
Q2 | $741K | Hold |
34,418
| – | – | 0.01% | 579 |
|
|
2024
Q1 | $927K | Hold |
34,418
| – | – | 0.01% | 532 |
|
|
2023
Q4 | $1.03M | Buy |
34,418
+3,859
| +13% | +$116K | 0.01% | 498 |
|
|
2023
Q3 | $626K | Sell |
30,559
-26,365
| -46% | -$540K | 0.01% | 546 |
|
|
2023
Q2 | $1.13M | Buy |
56,924
+30,132
| +112% | +$599K | 0.02% | 469 |
|
|
2023
Q1 | $459K | Buy |
26,792
+2,639
| +11% | +$45.2K | 0.01% | 566 |
|
|
2022
Q4 | $473K | Buy |
24,153
+6,361
| +36% | +$124K | 0.01% | 566 |
|
|
2022
Q3 | $284K | Buy |
17,792
+1,604
| +10% | +$25.6K | 0.01% | 645 |
|
|
2022
Q2 | $223K | Hold |
16,188
| – | – | ﹤0.01% | 699 |
|
|
2022
Q1 | $257K | Buy |
+16,188
| New | +$257K | ﹤0.01% | 717 |
|